Improved clinical outcomes and physical activity in patients with rheumatoid arthritis treated with originator adalimumab in routine clinical practice
Journal Title: International Journal of Clinical Rheumatology - Year 2018, Vol 13, Issue 6
Abstract
Background/Objective: We aimed at evaluating changes in habitual physical activity, disease activity and physical function following treatment with originator adalimumab (ADAORIG) in patients with Rheumatoid Arthritis (RA) in routine clinical practice. Methods: This observational study followed RA patients for 12 months, using the DAS28, HAQ-DI and Short QUestionnaire to ASsess Health-enhancing physical activity (SQUASH) instruments to measure disease activity, physical function and habitual physical activity, respectively. Associations of SQUASH scores with DAS28, HAQ-DI and socio-demographic factors were evaluated by correlation coefficients and multivariable regression analyses. Results: From baseline to final visit, the mean SQUASH total score increased from 4772 ± 4132 to 6104 ± 4921 (n=460), representing a 28% improvement in overall physical activity. Largest improvements were observed in the domains of leisure time and sport (42%), and activities at work and school (35%). Mean DAS28 and HAQ-DI scores decreased by 2.8 and 0.7 points, respectively, but a sizeable negative correlation was found only between baseline SQUASH total score and HAQ-DI score (–0.30; p<0.0001). Advancing age was negatively associated with the final SQUASH total score (effect estimate of –46.2, p<0.05). Conclusion: Improvements in habitual physical activity, disease activity, and physical function were observed in RA patients after 12 months of ADAORIG therapy.
Authors and Affiliations
Dmitry Karateev, Bernadette Rojkovich, Maja Hojnik, Orsolya Nagy, Catalin Codreanu
Keywords
Related Articles
- EP ID EP604801
- DOI -
- Views 69
- Downloads 0
Mobile health applications in rheumatology: Could they improve our care and research?
With>165,000 mobile health apps available on iTunes and Google Play mHealth is a rapidly growing field, which generated high expectations for the improvement of our health care. We identify two uses for mHealth in the fi...
Cardiovascular disease is associated with activity limitations in osteoarthritis patients
Background: To investigate the associations between Cardiovascular Disease (CVD) and Cardiovascular (CV) risk factors with activity limitations in patients with knee or hip Osteoarthritis (OA). Methods and Findings: Cons...
Refractory thrombocytopenia in SLE patient with massive thigh hematoma and hematuria successfully treated with Rituximab: Case Report
Background: Systemic Lupus Erythematosus is a multisystemic inflammatory disease with broad clinical presentation, 9.5% to 44.5% of patients with SLE have thrombocytopenia complication of different grades. No significant...
Favorable outcome of allogenic hematopoietic stem cell transplantation in farber disease
Farber disease is a rare autosomal recessively inherited disorder caused by acid ceramidase deficiency. Painful subcutaneous skin nodules, progressive joint stiffness, and laryngeal involvement leading to a progressive h...
Peripheral blood biomarkers in systemic sclerosis -associated interstitial lung diseases
Interstitial lung disease (ILD) can lead to significant morbidity and excess mortality in systemic sclerosis (SSc) patients. The early identification of patients at risk of progressive ILD is the main challenges for trea...